Article
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich…
medRxiv · 2021 · Deanna M Tiek
Key facts
| Title | Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug resistant gliomas |
|---|---|
| First author | Deanna M Tiek |
| Journal | medRxiv |
| Published | Nov 21, 2021 |
| DOI | 10.1101/661660 |
| Devices mentioned | BK110039, DEN000008, K022086, K042884, K103302, K923652 |
| Product codes mentioned | JCI, KIP, KIT, KPA, MVU, MYA, MXZ, NDS, NJT, NKF, OOI, PFF and 3 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1